Skip to main content

Ling Qi

NIH Rank #494
  • Top 5% Funded
  • R01 Holder
  • Translational
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9335858Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Physiology
  • Internal Medicine

NIH Funding · FY2026

Linked Award Amount
$5.3M
Full award amounts, FY2026
Award Records
6
Records listing this PI
Award-Linked Rank
#494
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Ling Qi. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Ling Qi as a PI. Multi-PI records show the full award amount for context.

  • 4R01AG089640-03R01
    ERAD-STING Crosstalk in Microglia: Unraveling the Pathogenesis of Alzheimer's Disease
    $2.4M
    award amount
  • 2R01DK143292-10A1R01
    Secretory Pathway Protein Degradation Maintains Insulin Biogenesis + Secretion
    $786K
    award amount
  • 5R01DK120330-08R01
    Novel role of hepatic SEL1L-HRD1 ERAD in bile acid metabolism
    $683.7K
    award amount
  • 5R01NS138119-02R01
    Mechanisms Underlying the Pathogenesis of SEL1L-HRD1 ERAD Disease Variants
    $638.2K
    award amount
  • 5R01DK132786-04R01
    Mechanisms of ER-Protein Quality Control in Podocytes
    $403K
    award amount
  • 5R01DK137794-03R01
    A central role of SEL1L-HRD1 ERAD in LPL maturation in adipocytes
    $383.9K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Ling Qi as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Virginia
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2741
  6. 2024
    Entered Top 25% Nationally
    Ranked #2741
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  9. 2025
    R01 Grant Holder
  10. 2026
    $10M Cumulative Funding
  11. 2026
    Entered Top 10% Nationally
    Ranked #494
  12. 2026
    Entered Top 5% Nationally
    Ranked #494
Ling Qi | NIH Award Records | ConductScience